BTŪ Cosmetic from Allergan, a world leader in medical aesthetics, has become one of the most popular cosmetic treatments for the face. Due to restrictions from the TGA, the actual name of the anti-wrinkle injection cannot be used, so we’re using
AntiWrinkle Injection, BTŪ Cosmetic or simply BTŪ instead.
Men and women between the ages of 18 to 65 now have the ability to choose science-based, non-invasive medical aesthetic solutions. Since its approval, BTŪ Cosmetic has been the
most popular physician-administered aesthetic procedure in the Australia.
BTŪ is a simple, non-surgical procedure for temporarily reducing the appearance of
moderate to severe glabellar lines - the vertical frown lines between the eyebrows that look like an "11" - in adult women and men. It reduces the activity of the muscles that cause the "11s" to form by blocking nerve impulses that trigger wrinkle-causing muscle contractions, creating an improved appearance between the brows. Results can last up to four months and may vary with each patient.
Anti-Wrinkle Injections are now more than just treating wrinkles. For example, the face can be "sculpted" by
raising or lowering eyebrows to enhance your look. BTŪ is an excellent complimentary procedure to overall facial rejuvenation. It can be used alone or in combination with
facial fillers and skin care from
home treatments to
IPL skin rejuvenation.
It’s also used effectively to treat migranes, excessive sweating, reducing the size or roundness of face in the lower area of face (popular for Asian clients)
What BTŪ treats
- Glabellar lines: Deep furrows between the eyebrows. These are often referred to as the "angry 11's"
- Horizontal lines on the forehead and crows feet
- Platysma bands--the thick bands of muscle in front of the neck, BTŪŪ may help stave off a facelift
Dimpling of the chin from overactive muscles
- Raise drooping of the corners of the mouth
- Fine lines around the lips and under and around the eyes
- Excessive underarm sweating
There has not been a confirmed serious case of spread of toxin effect when BTŪ Cosmetic has been used at the recommended dose to treat frown lines.
Do not take BTŪ Cosmetic if you
- are allergic to any of the ingredients in BTŪ Cosmetic;
- had an allergic reaction to any other bo-toxin product such as MyoblocŪ or DyŪ
- have a skin infection at the planned injection
Tell your doctor or get medical help right away if you experience itchy
rash, swelling, and shortness of breath or similar symptoms. Further injection of BTŪ Cosmetic should be discontinued.
Tell your doctor about all your muscle or nerve conditions such as amyotrophic lateral sclerosis [ALS or Lou Gehrig’s disease], myasthenia gravis or Lambert-Eaton syndrome as you may be at increased risk of serious side effects.
Tell your doctor about all your medical conditions, including if you have:
- plans to have surgery
- had surgery on your face
- weakness of forehead muscles, such as trouble
raising your eyebrows
- drooping eyelids
- any other abnormal facial change
- are pregnant or plan to become pregnant (It is not known if BTŪ
Cosmetic can harm your unborn baby)
- are breast-feeding or plan to breastfeed (It is not known if BTŪ
Cosmetic passes into breast milk)
Tell your doctor about all the medicines you take, including prescription and nonprescription medicines, vitamins and herbal products.
BTŪ Cosmetic may cause loss of strength or general muscle weakness, or vision problems. If this happens, do not drive a car, operate machinery, or do other dangerous activities.
Other side effects of BTŪ Cosmetic include: dry mouth, discomfort or pain at the injection site, tiredness, headache, neck pain, and eye problems: double vision, blurred vision, decreased eyesight, drooping eyelids, swelling of your eyelids, and dry eyes.
BTŪ Cosmetic (onabotoxinA) for injection, is a sterile, vacuum-dried purified bo-toxin type A, produced from fermentation of Hall strain Clostridium bo-type A grown in a medium containing casein hydrolysate, glucose, and yeast extract, intended for intramuscular use.
It is purified from the culture solution by dialysis and a series of acid precipitations to a complex consisting of the neurotoxin, and several accessory proteins. The complex is dissolved in sterile sodium chloride solution containing Albumin Human and is sterile filtered (0.2 microns) prior to filling and vacuum-drying.
BTŪ and BTŪ Cosmetic Difference
BTŪ is a prescription medicine that is injected into muscles and used:
- to treat increased muscle stiffness in elbow, wrist,
and finger muscles in adults with upper limb spasticity
- to treat the abnormal head position and neck pain
that happens with cervical dystonia (CD) in adults
- to treat certain types of eye muscle problems
(strabismus) or abnormal spasm of the eyelids
(blepharospasm) in people 12 years and older
BTŪ is also injected into the skin to treat migraines as well as the symptoms of severe underarm sweating (severe primary axillary hyperhidrosis) when medicines used on the skin (topical) do not work well enough.
BTŪ Cosmetic is a prescription medicine that is injected into muscles and used to improve the look of moderate-to-severe frown lines between the eyebrows (glabellar lines) in adults younger than 65 years of age for a short period of time (temporary).
BTŪ Cosmetic is not recommended for use in children younger than 18 years of age.
Are you new to BTŪ Cosmetic? How get started
Schedule obligation free appointment with a doctor to determine if BTŪ Cosmetic is right for you. Dr
Merian Koh is a facial
aesthetics doctor, Victorian trainer for Merz Aesthetics. She offers other facial aesthetic treatments with vast experience injecting
- Prior to your appointment, consider your treatment
- During your appointment, discuss these treatment goals
with your doctor
- At your appointment discuss your treatment goals and ask your doctor if this anti
wrinkle injection is right for you
- See the results: Improvement may begin within 24-48
hours and your results may increase during the first
week after treatment and can continue to improve up to
30 days after treatment
- Long-lasting results up to 4 months
- Individual results may vary
Have you already been treated with BTŪ Cosmetic?
If you are pleased with your previous BTŪ Cosmetic results, you may want to consider a regular treatment plan to help maintain them. Don’t forget that you can receive injections every 3 to 4 months as long as you don't have any serious allergic reactions or other significant side effects.
If you find BTŪ no longer works because your body has
developed antibodies, why not to try
D™ Melbourne. D™ has fewer proteins surrounding the toxin and so should stimulate a weaker immune response to break down the toxin.
What Is the BTŪ Treatment?
The treatment process for BTŪ Cosmetic is simple.
No anesthesia is required. However, doctor may choose to numb the area with a cold pack or anesthetic cream. Discomfort is usually minimal and brief. Few tiny injections of BTŪŪ Cosmetic would be administered by doctor directly into the muscles that cause those moderate-to-severe frown lines between the brows.
It takes approximately 10 minutes for the entire treatment.
Doctor will give you specific aftercare instructions.
- Within days, you may see a marked improvement in the
moderate-to-severe frown lines between your brows. Lines
continue to improve for up to 30 days, and results can
last for up to 4 months. Individual results may vary
- Visible results have been shown to last up to 4
months. Your own results may vary – be sure to talk to
your healthcare provider about what you can expect and
when to schedule your next appointment
- Discomfort is usually minimal and brief. Prior to injection, your physician may choose to numb the area with a cold pack or anesthetic cream. The entire procedure takes approximately 10 minutes. Most patients are in and out of the physician’s office without downtime following BTŪ
- Side effects associated with the injection include
localized pain, infection, inflammation, tenderness,
swelling, swelling, redness, and/or bleeding/bruising
- Although the results are visible, a treatment with BTŪ
Cosmetic will not radically change your facial
appearance or make you look as if you’ve “had work
done.” The muscle activity that causes frown lines
between the brows is temporarily reduced, so you can
still frown or look surprised without the wrinkles and
creases between your brows
Anti-Wrinkle injections Clinical Studies
Two phase 3 randomized, multi-center, double-blind, placebo-controlled studies of identical design were conducted to evaluate BTŪ Cosmetic for use in the temporary improvement of the appearance of moderate to severe glabellar facial lines. The studies enrolled healthy adults (ages 18 to 75) with glabellar lines of at least moderate severity at maximum frown.
Patients were excluded if they had ptosis, deep dermal scarring, or an inability to substantially lessen glabellar lines even by physically spreading them apart. Subjects received a single treatment with BTŪ Cosmetic (N=405, combined studies) or placebo (N=132, combined studies).
Injection volume was 0.1 mL/injection site, for a dose/injection site in the active treatment groups of 4 Units. Subjects were injected intramuscularly in five sites, 1 in the procerus muscle and 2 in each corrugator supercilii muscle, for a total dose in the active treatment groups of 20 Units.
The co-primary efficacy endpoints were the investigator’s rating of glabellar line severity at maximum frown and the
subject’s global assessment of change in appearance of glabellar lines, both at Day 30 post-injection. For the investigator rating, using a 4-point grading scale (0=none, 3=severe) a responder was defined as having a severity grade of 0 or 1. For the subject’s global assessment of change, the ratings were from +4 (complete improvement) to -4 (very marked worsening). A responder was defined as having a grade of at least +2 (moderate improvement). After completion of the randomized studies, subjects were offered participation in an open label, repeat treatment study to assess the safety of repeated treatment sessions.
The combined results of these two efficacy trials were presented. The mean age was 46 years, with 32 patients (6%) ≥ 65 years of age. Most of the subjects (82%) were women, and Caucasian (84%). At baseline, 210 patients (39%) had glabellar line severity scores at rest of moderate or severe.
In these studies, the severity of glabellar lines was reduced for up to 120 days in the BTŪŪ Cosmetic group compared to the placebo group as measured both by investigator rating of glabellar line severity at maximum frown , and by subject’s global assessment of change in appearance of glabellar lines.
Overall best result for “Assessment of Glabellar Line Severity at Maximum Frown – Responder Rates” and “Subject’s Assessment of Change in Appearance of Glabellar Lines – Responder Rates” were achieved at day 30 with BTŪ Cosmetic patients see around
Analyses by gender suggested that responder rates in the BTŪ Cosmetic treated group were higher for women than for men for both the investigator assessment (day 30; 85% of 334 women, 59% of 71 men) and the Subject Assessment (day 30; 93% of women, 72% of men).
In the limited number of non-Caucasian patients the responder rates were similar to those observed in the Caucasian patients.